386 related articles for article (PubMed ID: 10514580)
1. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Thussu A; Barman CR; Prabhakar S
Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
[TBL] [Abstract][Full Text] [Related]
2. [Blepharospasm and hemifacial spasm treated with botulinum A toxin injection].
Wang J; Lin S; Zhang X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):291-3. PubMed ID: 11717871
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment with botulinum toxin: dosage, treatment schedules and costs].
Schnider P; Birner P; Moraru E; Auff E
Wien Klin Wochenschr; 1999 Jan; 111(2):59-65. PubMed ID: 10081123
[TBL] [Abstract][Full Text] [Related]
4. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
5. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
Quagliato EM; Carelli EF; Viana MA
Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784
[TBL] [Abstract][Full Text] [Related]
7. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
8. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm.
Tsai CP; Chiu MC; Yen DJ; Guo YC; Yuan CL; Lee TC
Acta Neurol Taiwan; 2005 Jun; 14(2):61-8. PubMed ID: 16008164
[TBL] [Abstract][Full Text] [Related]
10. Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin.
Gil Polo C; Rodríguez Sanz MF; Berrocal Izquierdo N; Castrillo Sanz A; Gutiérrez Ríos R; Zamora García MI; Mendoza Rodríguez A; Duarte García-Luis J
Neurologia; 2013 Apr; 28(3):131-6. PubMed ID: 22652139
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
13. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
Ziak P
Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A in blepharospasm and hemifacial spasm.
Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
Tan AK
Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin management of upper facial rhytidosis and blepharospasm.
Seiff SR; Zwick OM
Otolaryngol Clin North Am; 2005 Oct; 38(5):887-902. PubMed ID: 16214565
[No Abstract] [Full Text] [Related]
18. Botulinum toxin in the treatment of dystonias--a hospital based study.
Gupta M; Singh G; Khwaja G
J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections.
Saeliw P; Preechawai P; Aui-aree N
J Med Assoc Thai; 2010 Oct; 93(10):1200-4. PubMed ID: 20973324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
